Cardiac Magnetic Resonance (CMR) imaging techniques for Cardiovascular Disease

Medical University of South Carolina, Charleston, SC
Cardiovascular DiseaseCardiac Magnetic Resonance (CMR) imaging techniques - Other
18 - 90
All Sexes

Study Summary

This trial will test if a new MRI technique can help diagnose and treat patients with heart conditions.

Eligible Conditions
  • Cardiovascular Disease

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 years

2 years
Clinical value of fast T1, T2, and T2* mapping of the left ventricle for the assessment of necrosis/scar, edema, and possible intramyocardial hemorrhage in patients with heart disease.

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Additional 5 minute research MR scan of heart.
1 of 1

Experimental Treatment

240 Total Participants · 1 Treatment Group

Primary Treatment: Cardiac Magnetic Resonance (CMR) imaging techniques · No Placebo Group · N/A

Additional 5 minute research MR scan of heart.
Experimental Group · 1 Intervention: Cardiac Magnetic Resonance (CMR) imaging techniques · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
871 Previous Clinical Trials
5,368,640 Total Patients Enrolled
Joseph U. Schoepf, MDPrincipal InvestigatorMedical University of South Carolina
1 Previous Clinical Trials
149 Total Patients Enrolled

Eligibility Criteria

Age 18 - 90 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a medical condition that has been diagnosed or is suspected by your doctor.
You have a heart condition called myocarditis (group 4).

Frequently Asked Questions

Is the upper age limit of prospective participants in this study restricted to octogenarians?

"To be accepted into this trial, potential participants must fall between the age range of 18 and 90. On the other hand, 113 clinical trials are recruiting people younger than 18 while 843 target those beyond 65 years old." - Anonymous Online Contributor

Unverified Answer

Is enrollment presently open for the experiment?

"According to the online resource,, this medical trial is in progress and has been since June 20th 2014. The page was last updated on November 29th 2022." - Anonymous Online Contributor

Unverified Answer

Who should be the primary candidates for this experiment?

"This clinical trial admits 240 patients aged 18 to 90 with carditis. For admittance, participants must have one of the following: myocardial ischemia or infarction (group 1), hypertrophic cardiomyopathy (group 2), infiltrative cardiomyopathy (group 3) ,or myocarditis (group 4). Additionally, they must be previously diagnosed and referred for a clinically indicated CMR." - Anonymous Online Contributor

Unverified Answer

How many individuals are actively engaged in this clinical experiment?

"Yes, the data hosted on affirms that this research project is presently seeking participants. It was initially published on June 20th 2014 and its last update occurred on November 29th 2022. The trial needs to enlist 240 patients from 1 centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.